These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25359880)

  • 1. Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.
    Sham JG; Kievit FM; Grierson JR; Chiarelli PA; Miyaoka RS; Zhang M; Yeung RS; Minoshima S; Park JO
    J Nucl Med; 2014 Dec; 55(12):2032-7. PubMed ID: 25359880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.
    Sham JG; Kievit FM; Grierson JR; Miyaoka RS; Yeh MM; Zhang M; Yeung RS; Minoshima S; Park JO
    J Nucl Med; 2014 May; 55(5):799-804. PubMed ID: 24627434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-3 targeted delivery of
    Labadie KP; Ludwig AD; Lehnert AL; Hamlin DK; Kenoyer AL; Sullivan KM; Daniel SK; Mihailovic TN; Sham JG; Orozco JJ; Yeung RS; Chen DL; Wilbur DS; Miyaoka RS; Park JO
    Sci Rep; 2021 Feb; 11(1):3731. PubMed ID: 33580090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma.
    Labadie KP; Lehnert AL; Kenoyer AL; Hamlin DK; Ludwig AD; Utria AF; Daniel SK; Mihailovic TN; Prossnitz A; Orozco JJ; Li Y; Wilbur DS; Miyaoka RS; Park JO
    EJNMMI Res; 2023 Apr; 13(1):35. PubMed ID: 37103671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
    Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
    Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET.
    Fayn S; King AP; Gutsche NT; Duan Z; Buffington J; Olkowski CP; Fu Y; Hong J; Sail D; Baidoo KE; Swenson RE; Cheloha RW; Ho M; Choyke PL; Escorcia FE
    J Nucl Med; 2023 Jul; 64(7):1017-1023. PubMed ID: 36997331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
    Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
    J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glypican-3-Targeted
    Labadie KP; Hamlin DK; Kenoyer A; Daniel SK; Utria AF; Ludwig AD; Kenerson HL; Li L; Sham JG; Chen DL; Orozco JJ; Yeung RS; Orvig C; Li Y; Wilbur DS; Park JO
    J Nucl Med; 2022 Jul; 63(7):1033-1038. PubMed ID: 34772791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Evaluation of CD20 Expression Using
    Kang L; Li C; Rosenkrans ZT; Engle JW; Wang R; Jiang D; Xu X; Cai W
    J Nucl Med; 2021 Mar; 62(3):372-378. PubMed ID: 32826320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.
    Wang Z; Han YJ; Huang S; Wang M; Zhou WL; Li HS; Wang QS; Wu HB
    Amino Acids; 2018 Feb; 50(2):309-320. PubMed ID: 29204748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.
    Yang X; Liu H; Sun CK; Natarajan A; Hu X; Wang X; Allegretta M; Guttmann RD; Gambhir SS; Chua MS; Cheng Z; So SK
    Biomaterials; 2014 Aug; 35(25):6964-71. PubMed ID: 24836949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
    Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
    Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate.
    Waaijer SJ; Giesen D; Ishiguro T; Sano Y; Sugaya N; Schröder CP; de Vries EG; Lub-de Hooge MN
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma.
    Dickerson LK; Lehnert AL; Hamlin DK; Labadie KP; Goodsell KE; Liu Y; Li Y; Wilbur DS; Miyaoka R; Park JO
    Res Sq; 2024 Jun; ():. PubMed ID: 38978570
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Cheng Y; Shi D; Xu Z; Gao Z; Si Z; Zhao Y; Ye R; Fu Z; Fu W; Yang T; Xiu Y; Lin Q; Cheng D
    Mol Pharm; 2022 Oct; 19(10):3551-3562. PubMed ID: 35244407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
    Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
    Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preclinical evaluation of a novel probe [
    Mo C; Sun P; Liang H; Chen Z; Wang M; Fu L; Huang S; Tang G
    Bioorg Chem; 2024 Jun; 147():107352. PubMed ID: 38640719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low glucose metabolism in hepatocellular carcinoma with GPC3 expression.
    Li YC; Yang CS; Zhou WL; Li HS; Han YJ; Wang QS; Wu HB
    World J Gastroenterol; 2018 Jan; 24(4):494-503. PubMed ID: 29398870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma.
    Ludwig AD; Labadie KP; Seo YD; Hamlin DK; Nguyen HM; Mahadev VM; Yeung RS; Wilbur DS; Park JO
    J Oncol; 2019; 2019():4564707. PubMed ID: 31636665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.